Abstract:HCA-7 human colorectal cancer cells were transfected with miRNA precursor forms, pre-miR-143 or pre-miR-145; or c-Myc siRNA or scrambled oligonucleotides using Lipofectamine.Colon cancer cell or colonic fibroblast EGFR was activated with EGF or inhibited with C225 anti-EGFR antibodies.Western blotting was used to assess G1 cell cycle regulators: c-Myc, cdk6, cyclin D2, E2F3 and pRb.Northern blotting and real time PCR were used to measure miR-143 and miR-145.Cell proliferation and DNA synthesis were measured by WST-1 and BrdU incorporation, respectively.Results: Northern blotting confirmed low levels of miR-143 and miR-145 in human colon cancers and cell lines.As in the case of human cancers, miR-143 and miR-145 were down-regulated 90% in colonic tumors of mice with wt EGFR.In striking contrast, these miRNA were increased 4-5-fold in tumors from Wa2 Egfr mice.Wa2 mutations nearly abolish receptor kinase activity In Vitro.Up-regulations of pre-miR-143 or pre-miR-145 by transfection caused 60-70% reduction in proliferation and inhibited DNA synthesis by 80-90% in HCT116 cells, consistent with a tumor suppressor role for these miRNA.Modulating EGFR signals caused parallel changes in c-Myc, while inducing inverse changes in miR-143 and miR-145 in cancer cells (C225-treated) and fibroblasts (EGF-treated).c-Myc siRNA knock-down also increased miR-143 and miR-145 by 50-95% in cancer cells, while decreasing c-Myc ~90%, suggesting c-Myc mediates EGFR suppression of these miRNAs.Compared to control, EGF increased cdk6, pRb and E2F3, whereas C225 antibodies reduced these proteins in cancer cells, identifying these G1 regulators as EGFR targets.In contrast, pre-miR-143 and pre-miR-145 reduced these G1 regulators by 30-60% in HCT116 cells, suggesting they are also functional targets of miR-143 and miR-145.Conclusion: These studies suggest that EGFR proliferation is mediated by c-Myc via inhibition of miR-143 and miR-145.Furthermore, we have demonstrated for the first time that these miRNA negatively control G1 cell cycle regulators.

Inhibition of Mir-196A Affects Esophageal Cancer Cell Growth in Vitro.

Effect of Mir-196A Inhibition on Esophageal Cancer Growth in Vitro.

Mir-129-5p Attenuates Cell Proliferation and Epithelial Mesenchymal Transition Via HMGB1 in Gastric Cancer

Mir-302B Inhibits Cancer-Related Inflammation by Targeting ERBB4, IRF2 and CXCR4 in Esophageal Cancer

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

Increased Mir-203-3p and Reduced Mir-21-5p Synergistically Inhibit Proliferation, Migration, and Invasion in Esophageal Cancer Cells

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Differential Expression of Mir-195 in Esophageal Squamous Cell Carcinoma and Mir-195 Expression Inhibits Tumor Cell Proliferation and Invasion by Targeting of Cdc42.

Mir-196A Regulates the Proliferation, Invasion and Migration of Esophageal Squamous Carcinoma Cells by Targeting ANXA1.

Mir-1 Suppresses the Growth of Esophageal Squamous Cell Carcinoma in Vivo and in Vitro Through the Downregulation of MET, Cyclin D1 and CDK4 Expression.

Regulation of Β-Catenin-mediated Esophageal Cancer Growth and Invasion by Mir-214.

Mir-195 Regulates Proliferation and Apoptosis Through Inhibiting the Mtor/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.

Effects of Mir‑138‑5p and Mir‑204‑5p on the Migration and Proliferation of Gastric Cancer Cells by Targeting EGFR.

Overexpression of Mir-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma

Mir-145 Inhibits Proliferation And Invasion Of Esophageal Squamous Cell Carcinoma In Part By Targeting C-Myc

MiR-195-5p Reduces Esophageal Cancer Cell Proliferation Through The IGF-1R/AKT Axis

MiR-196a promotes the proliferation and migration of esophageal cancer via the UHRF2/TET2 axis

Inhibition of Mir‑194 Suppresses the Wnt/β‑catenin Signalling Pathway in Gastric Cancer.

Mir-455 Inhibits Cell Proliferation and Migration Via Negative Regulation of EGFR in Human Gastric Cancer.

Upregulated Mir-193A-3p As an Oncogene in Esophageal Squamous Cell Carcinoma Regulating Cellular Proliferation, Migration and Apoptosis.

Mir-211 Inhibits Cell Epithelial-Mesenchymal Transition by Targeting Mmp9 in Gastric Cancer